Document is current
Any future updates will be listed below
-
Authors
de Moraes, Fabiano Moulin
Brasil, Sérgio
Frigieri, Gustavo
Robba, Chiara
Paiva, Wellingson
Silva, Gisele Sampaio
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05121155 at ClinicalTrials.govnct03144219 at ClinicalTrials.govDocuments that mention this clinical trial
ICP wave morphology as a screening test to exclude intracranial hypertension in brain-injured patients: a non-invasive perspective
https://doi.org/10.1007/s10877-023-01120-3
Documents that mention this clinical trial
ICP wave morphology as a screening test to exclude intracranial hypertension in brain-injured patients: a non-invasive perspective
https://doi.org/10.1007/s10877-023-01120-3
Application of non-invasive ICP waveform analysis in acute brain injury: Intracranial Compliance Scale
https://doi.org/10.1186/s40635-023-00492-9
- License Information
-
More Information
Article History
Received: 15 October 2023
Accepted: 15 December 2023
First Online: 14 February 2024
Declarations
:
: SB is a scientific advisor at Brain4care and GF is the founder and scientific director of Brain4care. The other authors have no competing interests.
: This study protocol was approved by our local Ethics Committee at under numbers 03843118.0.0000.5505 and 66721217.0.0000.0068 and registered at clinicaltrials.gov under numbers NCT05121155 (Registered 16 November 2021) and NCT03144219 (Registered 30 September 2022). All patients’ legal representative signed an informed consent form. The research performed in accordance with the Declaration of Helsinki.
: We Confirm adherence to ethical guidelines and indicate ethical approvals (IRB) and use of informed consent, as appropriate.
